Here are 4 forces that drove a tough week for stocks
It was a tough week for stocks as investors navigated everything from rising tensions in the Middle East to key…
Eli Lilly and company
UPS, FedEx and logistics giants are investing in the healthcare boom
A FedEx worker walks past his truck in the North Beach neighborhood on June 23, 2026 in San Francisco, California.…
Eli Lilly to apply for approval of anti-obesity drug retatrutide in 2027
The Eli Lilly logo appears at the company's office in San Diego, California, on November 21, 2025. Mike Blake |…
Cramer Says This Stock Is Significantly Undervalued And Sees 35% Upside
Every weekday, CNBC's Investment Club with Jim Cramer hosts a livestream “morning meeting” at 10:20 a.m. ET. Here's a recap…
Employers Are Not Expanding Coverage of GLP-1 Anti-Obesity Drugs: Survey
A version of this article first appeared in CNBC's Healthy Returns newsletter, bringing the latest healthcare news directly to your…
Walmart and CVS step in to help seniors
A version of this article first appeared in CNBC's Healthy Returns newsletter, bringing the latest healthcare news directly to your…
Medicare Will Soon Cover Obesity Medications, But Many Seniors May Not Know It
Wegovy weight loss treatment injectable pens, manufactured by Novo Nordisk A/S, on display during a press conference in Mumbai, India,…
Estrogen patches in short supply as women seek menopause support
Woman applying estrogen patch during hormone therapy. Half point images | Moment | fake images Estrogen patches are in short…
What's next for the weight-loss drug maker?
Shares in Danish biotech Zealand Pharma plunged recently after detailed data on its weight-loss drug survodutide showed much higher patient…
Lilly, Novo and Pfizer seek new weight loss drugs
Drug makers have only been introducing GLP-1 pills for a few months and are undergoing big changes to the way…